Salary Range:CHF102,200.00 - CHF189,800.00 BandLevel 4 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Internal Title: Data Scientist, Senior Expert I or II As a Senior Expert I/II, Data Science, you will join our Modeling & Simulation (M&S)
Salary Range:CHF146,300.00 - CHF271,700.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland or London, UK (see separate posting) As Senior Legal Counsel, you will play a pivotal role in shaping the future of Neuroscience and advancing breakthrough gene
Salary Range:CHF146,300.00 - CHF271,700.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland or London, UK (see separate posting). As Senior Legal Counsel TA Oncology, International, you will play a pivotal role in shaping the future of cancer care.
The Botnar Institute of Immune Engineering (BIIE) is a new interdisciplinary research institute dedicated to innovation in immune engineering. Founded in 2024 through a generous endowment from Fondation Botnar, the BIIE supports scientists in taking on
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About Idorsia Pharmaceuticals Ltd Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ (daridorexant), a different kind of
Salary Range: CHF146,300.00 - CHF271,700.00 Job Description Summary #LI-Hybrid Location: Basel, Switzerland or London, UK (see separate posting). As Senior Legal Counsel TA Oncology, International, you will play a pivotal role in shaping the future of
Salary Range: CHF146,300.00 - CHF271,700.00 Job Description Summary #LI-Hybrid Location: Basel, Switzerland or London, UK (see separate posting) Job Description As Senior Legal Counsel, you will play a pivotal role in shaping the future of Neuroscience
VP, Head of Global Access, Value and PricingLocation: Basel, BS, CHAbout Idorsia Pharmaceuticals LtdHeadquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from
Salary Range: CHF146,300.00 - CHF271,700.00 Band Level 6 Job Description Summary #LI-Hybrid Location: Basel, Switzerland or London, UK (see separate posting) As Senior Legal Counsel, you will play a pivotal role in shaping the future of
VP, Head of Global Access, Value and Pricing Location: Basel, BS, CH About Idorsia Pharmaceuticals Ltd Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering
Senior Clinical Pharmacologist Location: Allschwil, Basel Area, BL, CH The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines
Clinical Development Lead Location: Allschwil, Basel Area, BL, CH The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines
Salary Range: CHF146,300.00 - CHF271,700.00 Band Level 6 Job Description Summary #LI-Hybrid Location: Basel, Switzerland or London, UK (see separate posting). As Senior Legal Counsel TA Oncology, International, you will play a pivotal role in shaping
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)